Skip to content
← All treatment topics

TREATMENT READING

Childhood Tracheobronchial Tumors

Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

Health professional

Treatment of Childhood Tracheobronchial Tumors

Source: Childhood Tracheobronchial Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: January 6, 2025. Captured 2026-09-09.

The treatment of choice is conservative pulmonary resection, including sleeve segmental resection (when feasible), with the removal of the involved lymphatics.[1,2]; [3][Level of evidence B4]

Sources: 1 · 2 · 3 · Level of evidence B4

Chemotherapy and radiation therapy are not indicated for tracheobronchial tumors, unless evidence of metastasis is documented or the tumor is a rhabdomyosarcoma.

Treatment options for tracheobronchial tumors, according to histological type, are as follows:

This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.

Health professional · Treatment of Childhood Tracheobronchial Tumors

Carcinoid Tumors (Neuroendocrine Tumors of the Bronchus)

Source: Childhood Tracheobronchial Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: January 6, 2025. Captured 2026-09-09.

The treatment of choice is surgical resection with lymph node sampling. The overall survival rate is higher than 90% for these patients.[4-6] One study reported no deaths among patients who did not have lymph node involvement, and the 10-year survival rate was 89% for patients with one or more involved lymph nodes.[6]

Sources: 4 · 6 · 6

Health professional · Treatment of Childhood Tracheobronchial Tumors

Mucoepidermoid Carcinomas

Source: Childhood Tracheobronchial Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: January 6, 2025. Captured 2026-09-09.

The recommended treatment is open surgical resection and lymph node sampling. Endoscopic resection is not recommended.[7,8]

Sources: 7 · 8

Health professional · Treatment of Childhood Tracheobronchial Tumors

Inflammatory Myofibroblastic Tumors

Source: Childhood Tracheobronchial Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: January 6, 2025. Captured 2026-09-09.

The treatment of choice is surgery. However, if the tumor has an ALK variant, treatment with crizotinib may be effective.[8-11]

Sources: 8 · 11

Health professional · Treatment of Childhood Tracheobronchial Tumors

Rhabdomyosarcomas

Source: Childhood Tracheobronchial Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: January 6, 2025. Captured 2026-09-09.

Surgery is not indicated. These tumors are very responsive to chemotherapy and radiation therapy, even with lymph node metastasis.[8] For more information, see Childhood Rhabdomyosarcoma Treatment.

Sources: 8 · Childhood Rhabdomyosarcoma Treatment

Health professional · Treatment of Childhood Tracheobronchial Tumors

Granular Cell Tumors

Source: Childhood Tracheobronchial Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: January 6, 2025. Captured 2026-09-09.

Surgical resection is based on morbidity risk.[8,12,13]

Sources: 8 · 12 · 13

For information about other neuroendocrine carcinoid tumors, see Pediatric Gastrointestinal Neuroendocrine Tumors Treatment.

Sources: Pediatric Gastrointestinal Neuroendocrine Tumors Treatment

Health professional

Treatment Options Under Clinical Evaluation for Childhood Tracheobronchial Tumors

Source: Childhood Tracheobronchial Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: January 6, 2025. Captured 2026-09-09.

Information about National Cancer Institute (NCI)–supported clinical trials can be found on the NCI website. For information about clinical trials sponsored by other organizations, see the ClinicalTrials.gov website.

Sources: NCI website · ClinicalTrials.gov website

Health professional

Special Considerations for the Treatment of Children With Cancer

Source: Childhood Tracheobronchial Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: January 6, 2025. Captured 2026-09-09.

Cancer in children and adolescents is rare, although the overall incidence has slowly increased since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of the following pediatric specialists and others to ensure that children receive treatment, supportive care, and rehabilitation to achieve optimal survival and quality of life:

Sources: 1

Primary care physicians.

Pediatric surgeons.

Pathologists.

Pediatric radiation oncologists.

Pediatric medical oncologists and hematologists.

Ophthalmologists.

Rehabilitation specialists.

Pediatric oncology nurses.

Social workers.

Child-life professionals.

Psychologists.

Nutritionists.

For specific information about supportive care for children and adolescents with cancer, see the summaries on Supportive and Palliative Care.

Sources: Supportive and Palliative Care

The American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of children and adolescents with cancer.[2] At these centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate is offered to most patients and their families. Clinical trials for children and adolescents diagnosed with cancer are generally designed to compare potentially better therapy with current standard therapy. Other types of clinical trials test novel therapies when there is no standard therapy for a cancer diagnosis. Most of the progress in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI website.

Sources: 2 · NCI website

Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2020, childhood cancer mortality decreased by more than 50%.[3-5] Childhood and adolescent cancer survivors require close monitoring because side effects of cancer therapy may persist or develop months or years after treatment. For information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors, see Late Effects of Treatment for Childhood Cancer.

Sources: 3 · 5 · Late Effects of Treatment for Childhood Cancer

Childhood cancer is a rare disease, with about 15,000 cases diagnosed annually in the United States in individuals younger than 20 years.[6] The U.S. Rare Diseases Act of 2002 defines a rare disease as one that affects populations smaller than 200,000 people in the United States. Therefore, all pediatric cancers are considered rare.

Sources: 6 · Rare Diseases Act of 2002

The designation of a rare tumor is not uniform among pediatric and adult groups. In adults, rare cancers are defined as those with an annual incidence of fewer than six cases per 100,000 people. They account for up to 24% of all cancers diagnosed in the European Union and about 20% of all cancers diagnosed in the United States.[7,8] In children and adolescents, the designation of a rare tumor is not uniform among international groups, as follows:

Sources: 7 · 8

A consensus effort between the European Union Joint Action on Rare Cancers and the European Cooperative Study Group for Rare Pediatric Cancers estimated that 11% of all cancers in patients younger than 20 years could be categorized as very rare. This consensus group defined very rare cancers as those with annual incidences of fewer than two cases per 1 million people. However, three additional histologies (thyroid carcinoma, melanoma, and testicular cancer) with incidences of more than two cases per 1 million people were also included in the very rare group due to a lack of knowledge and expertise in the management of these tumors.[9]

Sources: 9

The Children's Oncology Group defines rare pediatric cancers as those listed in the International Classification of Childhood Cancer subgroup XI, which includes thyroid cancers, melanomas and nonmelanoma skin cancers, and multiple types of carcinomas (e.g., adrenocortical carcinomas, nasopharyngeal carcinomas, and most adult-type carcinomas such as breast cancers and colorectal cancers).[10] These diagnoses account for about 5% of the cancers diagnosed in children aged 0 to 14 years and about 27% of the cancers diagnosed in adolescents aged 15 to 19 years.[4] Most cancers in subgroup XI are either melanomas or thyroid cancers, with other cancer types accounting for only 2% of the cancers diagnosed in children aged 0 to 14 years and 9.3% of the cancers diagnosed in adolescents aged 15 to 19 years.

Sources: 10 · 4

These rare cancers are extremely challenging to study because of the relatively few patients with any individual diagnosis, the predominance of rare cancers in the adolescent population, and the small number of clinical trials for adolescents with rare cancers.

For patients

Treatment of childhood tracheobronchial tumors

Source: Childhood Tracheobronchial Tumors (PDQ®)–Patient Version, National Cancer Institute.

Source updated: October 11, 2024. Captured 2026-09-09.

There are different types of treatment for children and adolescents with tracheobronchial tumors. You and your child's care team will work together to decide treatment. Many factors will be considered, such as your child's overall health and whether the tumor is newly diagnosed or has come back after treatment.

Your child's treatment plan will include information about the tumor, the goals of treatment, treatment options, and the possible side effects. It will be helpful to talk with your child's care team before treatment begins about what to expect. For help every step of the way, see our booklet, Children with Cancer: A Guide for Parents.

Sources: Children with Cancer: A Guide for Parents

For all tracheobronchial tumors except rhabdomyosarcoma, treatment might include surgery to remove the tumor. The lymph nodes and vessels where cancer has spread are also removed. Sometimes a surgery called a sleeve resection is done.

Sources: vessels · sleeve resection

For rhabdomyosarcoma in the trachea or bronchi, treatment might include:

Chemotherapy (also called chemo) uses drugs to stop the growth of cancer cells. Chemotherapy either kills the cancer cells or stops them from dividing. Chemotherapy may be given alone or with other types of treatment.

Radiation therapy uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. External beam radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer.

Learn more about Childhood Rhabdomyosarcoma Treatment.

Sources: Childhood Rhabdomyosarcoma Treatment

For inflammatory myofibroblastic tumors in the trachea or bronchi, in addition to surgery, treatment may include targeted therapy. Targeted therapy uses drugs or other substances to identify and attack specific cancer cells. Crizotinib may be used if the tumor has a certain change in the ALK gene. Learn more about Targeted Therapy to Treat Cancer.

Sources: Crizotinib · ALK · Targeted Therapy to Treat Cancer

If the cancer comes back after treatment, your child's doctor will talk with you about what to expect and possible next steps. There might be treatment options that may shrink the cancer or control its growth. If there are no treatments, your child can receive care to control symptoms from cancer so they can be as comfortable as possible.

For patients

Side effects and late effects of treatment

Source: Childhood Tracheobronchial Tumors (PDQ®)–Patient Version, National Cancer Institute.

Source updated: October 11, 2024. Captured 2026-09-09.

Cancer treatments can cause side effects. Which side effects your child might have depends on the type of treatment they receive, the dose, and how their body reacts. Talk with your child's treatment team about which side effects to look for and ways to manage them.

To learn more about side effects that begin during treatment for cancer, visit Side Effects.

Sources: side effects · Side Effects

Problems from cancer treatment that begin 6 months or later after treatment and continue for months or years are called late effects. Late effects of cancer treatment may include:

physical problems

changes in mood, feelings, thinking, learning, or memory

second cancers (new types of cancer) or other conditions

Some late effects may be treated or controlled. It is important to talk with your child's doctors about the possible late effects caused by some treatments.

Disease and treatment settings

Childhood Tracheobronchial Tumors

Disease and treatment setting

Tracheobronchial Tumors in children and adolescents